Giant Cell Arteritis
Giant cell arteritis is an inflammatory condition that affects the blood vessels, particularly those in the head and neck, leading to symptoms like headaches, scalp tenderness, and vision problems.
Giant Cell Arteritis: Imaging Study with [18F]fluor-PEG-folate
We are investigating how well a special imaging technique shows changes in arteries of patients with giant cell arteritis before and after treatment. This may help us understand the disease better and improve future care.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 50 years old or older?
- Do you have symptoms like fatigue, fever, weight loss, or pain in your shoulders or hips?
- Have you started or increased any steroid medications in the last 4 weeks?
- Have you started any new disease-modifying medications in the last 3 months?
- Are you currently pregnant or breastfeeding?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Fluoro-peg-folate
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam University Medical Center, VUmc Boelelaan
Rheumatology and Clinical Immunology
Amstelveen, Netherlands
Universitair Medisch Centrum Groningen
Rheumatology and Clinical Immunology
Groningen, Netherlands
Sponsor: Universitair Medisch Centrum Groningen
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.